Combined effect of CYP17 and HSD17B1 high-risk alleles on riska of advanced breast cancer among women weighing 170 lbs. or less
. | No. of high-risk allelesb . | . | . | . | . | P (trend) . | ||||
---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 4 . | . | ||||
Subjects weighing ≤170 lbs. | ||||||||||
Controls (n = 1116) | 109 | 319 | 406 | 247 | 35 | |||||
Advanced cases (n = 178) | 13 | 44 | 64 | 44 | 13 | |||||
RRc | 1.00 | 1.17 | 1.29 | 1.48 | 3.05 | |||||
95% CI | (0.61–2.26) | (0.68–2.43) | (0.76–2.86) | (1.29–7.25) | 0.02 |
. | No. of high-risk allelesb . | . | . | . | . | P (trend) . | ||||
---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 4 . | . | ||||
Subjects weighing ≤170 lbs. | ||||||||||
Controls (n = 1116) | 109 | 319 | 406 | 247 | 35 | |||||
Advanced cases (n = 178) | 13 | 44 | 64 | 44 | 13 | |||||
RRc | 1.00 | 1.17 | 1.29 | 1.48 | 3.05 | |||||
95% CI | (0.61–2.26) | (0.68–2.43) | (0.76–2.86) | (1.29–7.25) | 0.02 |